ADT Exercise Trial and Economic Analysis (ADTExRCT)

April 11, 2021 updated by: University Health Network, Toronto

A Randomized Control Trial (RCT) and Economic Analysis of Two Exercise Delivery Methods in Men With Prostate Cancer on ADT

Prostate Cancer (PC) affects 1 in 7 men. Nearly half of those diagnosed with PC will receive androgen deprivation therapy (ADT) as part of their treatment. ADT is good at managing PC but has many side effects. Researchers have shown that exercise, specifically one-on-one supervised exercise improves many of the side effects of ADT. However, exercise programs for men on ADT are not widely available. More questions need to be answered in order for exercise programs to become part of PC treatment. First, can programs that require fewer resources, such as group-exercise or home-based exercise, also improve ADT side-effects? Second, do exercise-related benefits continue beyond the structured exercise program? And what makes people continue exercising? Third, which exercise program is most cost-effective?

In this study, the investigators will compare: (a) group supervised in-centre and (b) home-based supported exercise programs to see which program is most effective for men with PC on ADT. The investigators will also look at what motivates people to continue to exercise both during a structured program and after the program is complete and will examine which exercise program is most cost-effective.

Participants (men with PC on ADT) will be recruited from one of the following cancer centres: Princess Margaret Cancer Centre in Toronto, the Tom Baker Cancer Centre in Calgary, the Southlake Regional Health Centre in Newmarket, and Scarborough and Rouge Hospital - Centenary Site in Scarborough. When a patient agrees to participate, patient will be randomly placed in 1 of 2 exercise programs. All programs will include the same type of exercises (aerobic, resistance and flexibility) and all participants will exercise 4-5 days per week for 30 minutes per day (as tolerated) for the length of the program (6 months). The investigators will look at how men with PC on ADT respond to the exercise program by measuring quality of life (QOL), fatigue and different physical measures before, during, and after the exercise program.

Although the investigators know that supervised one-on-one exercise is most effective at improving ADT side-effects, it is unknown if other forms of exercise are just as beneficial and more financially responsible. This study will allow the investigators to begin to answer these questions so that structured exercise programs become a regular part of PC treatment.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2N 1N4
        • University of Calgary/Tom Baker Cancer Centre
    • Ontario
      • Newmarket, Ontario, Canada
        • Southlake Regional Health Centre
      • Toronto, Ontario, Canada, M1P 2T7
        • Scarborough and Rouge Hospital
      • Toronto, Ontario, Canada, M5G2C4
        • Princess Margaret Cancer Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • men with histologically confirmed PC who are starting or continuing on ADT for at least 6 months or who are in an androgen-deprived (or castrate) state for the duration of the intervention
  • fluent in English
  • able to provide consent
  • close to a study centre

Exclusion Criteria:

  • already meeting guidelines for moderate to vigorous physical activity (MVPA) - conditions that would interfere with ability to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group-Supervised
This intervention arm will include 3 group, supervised sessions per week for 6 months with a certified exercise specialist. Supervised sessions will be delivered in a group format with 4-8 participants per group. Flexibility training will include stretching for 5-10 minutes at the beginning and end of each session. Aerobic training will involve 30 minutes of low-impact step aerobics. Resistance training will be conducted using resistance bands, a stability ball, and an exercise mat with 8 prescribed exercises that target the major muscle groups. Participants will be encouraged to perform exercises independently on additional days, for a total of 4-5 days per week of exercise.
The exercise program will be delivered in a group format (4-8 participants per group) by a certified exercise specialist.
Experimental: Home-Based
The same protocol and training frequency as the supervised programs described above will be followed. However, all exercises will be completed independently by participants. Specific exercises in the aerobic program may be modified to accommodate patient preference (same target heart rate range as the supervised group). Participants will be supported with smartphone technology and remote 'health coaches' during the intervention phase. This will help to ensure participant adherence, appropriate progression, and safety.
The exercise program will be executed independently by participants in a home-based setting. Home-based participants will be supported with remote health coaching and smartphone technology.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Assessment of Cancer Therapy-Fatigue (FACT-F)
Time Frame: Every 3 Months for 12 Months
The FACT-F is a questionnaire that includes 13 items measuring cancer-related fatigue.
Every 3 Months for 12 Months
6 Minute Walk Test (6MWT)
Time Frame: Every 3 Months for 12 Months
The 6MWT is a commonly used, validated measure that assesses functional endurance.
Every 3 Months for 12 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Assessment of Cancer Therapy-General (FACT-G)
Time Frame: Every 3 Months for 12 Months
The FACT-G is a questionnaire that is well-validated and widely used to measure quality of life (QOL).
Every 3 Months for 12 Months
Functional Assessment of Cancer Therapy-Prostate (FACT-P)
Time Frame: Every 3 Months for 12 Months
The FACT-P is a questionnaire that supplements the FACT-G with 12 prostate-specific items covering domains of urinary function, sexual function, pain, and related symptoms.
Every 3 Months for 12 Months
5 Times Sit to Stand Test
Time Frame: Every 3 Months for 12 Months
A common, simple, and validated measure of functional lower body strength.
Every 3 Months for 12 Months
Grip Strength
Time Frame: Every 3 Months for 12 Months
Grip strength is a measure of upper body strength and predicts long-term disability and mortality in middle-aged and older adults.
Every 3 Months for 12 Months
Bioelectrical Impedance Analysis
Time Frame: Every 6 Months for 12 Months
Body composition will be measured using bioelectrical impedance analysis (BIA).
Every 6 Months for 12 Months
Waist Circumference and Hip Ratio
Time Frame: Every 6 Months for 12 Months
Body composition will be measured using waist circumference(WC) and WC:hip ratio, following the standardized Canadian Society for Exercise Physiology - Physical Activity Training for Health (CSEP-PATH) protocol.
Every 6 Months for 12 Months
Body Mass Index
Time Frame: Every 6 Months for 12 Months
Body composition will be measured using body mass index (BMI).
Every 6 Months for 12 Months
Bone Mineral Density (BMD)
Time Frame: Every 6 Months for 12 Months
Bone mineral density will be measured at lumbar spine, hip, and distal 1/3 radius using dual x-ray absorptiometry (DXA).
Every 6 Months for 12 Months
Biological Outcomes (blood work)
Time Frame: Every 6 Months for 12 Months
Fasting lipids, blood glucose, glycated hemoglobin, hemoglobin, prostate-specific antigen (PSA), and testosterone will be measured. Serum banking will also be done for use in future studies.
Every 6 Months for 12 Months
Sedentary Behaviour
Time Frame: Every 6 Months for 12 Months (unless otherwise specified)
Time spent in activities that are characterized by an energy expenditure ≤ 1.5 metabolic equivalents and a sitting or reclining posture (sedentary behavior) will be assessed using the Sedentary Behaviour Questionnaire that is used in large cohort studies and has demonstrated evidence of reliability and validity.
Every 6 Months for 12 Months (unless otherwise specified)
Planning, Attitudes, & Barriers scale
Time Frame: Every 6 Months for 12 Months (unless otherwise specified)
The Planning, Attitudes, & Barriers scale is a validated questionnaire that will be used to assess likelihood of exercise behavior over time.
Every 6 Months for 12 Months (unless otherwise specified)
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2)
Time Frame: Every 6 Months for 12 Months (unless otherwise specified)
Behavioral Regulations in Exercise Questionnaire-2 (BREQ-2) is a validated questionnaire that assess predictors of adherence.
Every 6 Months for 12 Months (unless otherwise specified)
Psychological Need Support and Frustration Scale - Relatedness Items
Time Frame: Every 6 Months for 12 Months (unless otherwise specified)
Relatedness will be assessed using the Psychological Need Support and Frustration Scale - Relatedness Items.
Every 6 Months for 12 Months (unless otherwise specified)
Health Care Climate Questionnaire (HCCQ)
Time Frame: Baseline only
The Health Care Climate Questionnaire (HCCQ short form) assess participant perceptions of their health care team.
Baseline only
Walkability
Time Frame: Baseline only
Participant postal codes will be collected to assess neighbourhood walkability (i.e., access to a grocery store within walking distance).
Baseline only
Disease-related Costs
Time Frame: Every 3 Months for 12 Months
The investigators will collect economically relevant data about health status using preference-based (utility) instruments (European Quality of Life Five Dimensions Questionnaire, EQ-5D). Productivity losses and out-of-pocket expenditures, in addition to hospitalization, drug co-pay, and health visit data will be gathered using a patient questionnaire.
Every 3 Months for 12 Months
Exercise Adherence
Time Frame: Every 3 Months for 12 Months
Both accelerometry and the Godin Leisure Time Exercise Questionnaire will be used as a measure of adherence at each time point. Both measures will provide a validated measure of physical activity.
Every 3 Months for 12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

March 31, 2020

Study Completion (Actual)

March 31, 2020

Study Registration Dates

First Submitted

June 2, 2016

First Submitted That Met QC Criteria

July 12, 2016

First Posted (Estimate)

July 15, 2016

Study Record Updates

Last Update Posted (Actual)

April 13, 2021

Last Update Submitted That Met QC Criteria

April 11, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 14-8158-CE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostate Cancer

Clinical Trials on Supervised Group Exercise

3
Subscribe